Literature DB >> 11287800

A possible role of apolipoprotein E polymorphism in predisposition to higher education.

J A Hubacek1, J Pitha, Z Skodová, V Adámková, V Lánská, R Poledne.   

Abstract

A potential candidate gene that could contribute to the education process is the apolipoprotein E (apo E) gene that has been shown to correlate with memory function and memory decline. We measured apo E polymorphism in groups of probands with different levels of education selected from a population sample. In the group of probands with higher education (n = 82), 24.4% had the e4 allele, compared with 7.3% who had the e2 allele. A reverse association was found in the group that left school aged 15 (n = 36) - 8.3% had the e4 allele and 13.9% had the e2 allele. Eighty-seven percent of the probands with the allele e4 reached higher education, compared to only 54.5% with the allele e2. The difference between the groups is statistically significant (p = 0.039), and this may indicate some role for the apo E polymorphism in subjects' intelligence or ability to learn. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287800     DOI: 10.1159/000054890

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  25 in total

Review 1.  Some evolutionary perspectives on Alzheimer's disease pathogenesis and pathology.

Authors:  Daniel J Glass; Steven E Arnold
Journal:  Alzheimers Dement       Date:  2011-12-03       Impact factor: 21.566

2.  The distribution of apolipoprotein E alleles in Scottish perinatal deaths.

Authors:  J-C Becher; J W Keeling; N McIntosh; B Wyatt; J Bell
Journal:  J Med Genet       Date:  2005-09-23       Impact factor: 6.318

3.  Sex, but not Apolipoprotein E Polymorphism, Differences in Spatial Performance in Young Adults.

Authors:  Alia L Yasen; Jacob Raber; Jeremy K Miller; Brian J Piper
Journal:  Arch Sex Behav       Date:  2015-03-07

4.  ApoE polymorphisms and diarrheal outcomes in Brazilian shanty town children.

Authors:  R B Oriá; P D Patrick; M O B Oriá; B Lorntz; M R Thompson; O G R Azevedo; R N B Lobo; R F Pinkerton; R L Guerrant; A A M Lima
Journal:  Braz J Med Biol Res       Date:  2010-03       Impact factor: 2.590

5.  Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer.

Authors:  Theresa A Koleck; Catherine M Bender; Susan M Sereika; Gretchen Ahrendt; Rachel C Jankowitz; Kandace P McGuire; Christopher M Ryan; Yvette P Conley
Journal:  Oncol Nurs Forum       Date:  2014-11-01       Impact factor: 2.172

6.  Apolipoprotein E4 and sex affect neurobehavioral performance in primary school children.

Authors:  Summer F Acevedo; Brian J Piper; Michael J Craytor; Ted S Benice; Jacob Raber
Journal:  Pediatr Res       Date:  2010-03       Impact factor: 3.756

7.  Positive effects of cholinergic stimulation favor young APOE epsilon4 carriers.

Authors:  Natalie L Marchant; Sarah L King; Naji Tabet; Jennifer M Rusted
Journal:  Neuropsychopharmacology       Date:  2010-01-13       Impact factor: 7.853

8.  Apolipoprotein E and traumatic brain injury in a military population: evidence of a neuropsychological compensatory mechanism?

Authors:  S Duke Han; Angela I Drake; Lynne M Cessante; Amy J Jak; Wes S Houston; Dean C Delis; J Vincent Filoteo; Mark W Bondi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-07       Impact factor: 10.154

9.  Clinical, cognitive, and genetic predictors of change in job status following traumatic brain injury in a military population.

Authors:  S Duke Han; Hideo Suzuki; Angela I Drake; Amy J Jak; Wes S Houston; Mark W Bondi
Journal:  J Head Trauma Rehabil       Date:  2009 Jan-Feb       Impact factor: 2.710

10.  Genetic factors influence the clustering of depression among individuals with lower socioeconomic status.

Authors:  Sandra López-León; Wing Chi Choy; Yurii S Aulchenko; Stephan J Claes; Ben A Oostra; Johan P Mackenbach; Cornelia M van Duijn; A Cecile J W Janssens
Journal:  PLoS One       Date:  2009-03-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.